{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HCC", "MARK4", "biological networks", "clinical relevance", "herbal drugs", "potential genes", "signaling pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35936719", "DateRevised": {"Year": "2023", "Month": "11", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "22"}], "Language": ["eng"], "ELocationID": ["914032", "10.3389/fonc.2022.914032"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.", "Pagination": {"StartPage": "914032", "MedlinePgn": "914032"}, "Abstract": {"AbstractText": ["MAP/microtubule affinity-regulating kinase 4 (MARK4) is associated with various biological functions, including neuronal migration, cell polarity, microtubule dynamics, apoptosis, and cell cycle regulation, specifically in the G1/S checkpoint, cell signaling, and differentiation. It plays a critical role in different types of cancers. Hepatocellular carcinoma (HCC) is the one of the most common forms of liver cancer caused due to mutations, epigenetic aberrations, and altered gene expression patterns. Here, we have applied an integrated network biology approach to see the potential links of MARK4 in HCC, and subsequently identified potential herbal drugs. This work focuses on the naturally-derived compounds from medicinal plants and their properties, making them targets for potential anti-hepatocellular treatments. We further analyzed the HCC mutated genes from the TCGA database by using cBioPortal and mapped out the MARK4 targets among the mutated list. MARK4 and Mimosin, Quercetin, and Resveratrol could potentially interact with critical cancer-associated proteins. A set of the hepatocellular carcinoma altered genes is directly the part of infection, inflammation, immune systems, and cancer pathways. Finally, we conclude that among all these drugs, Gingerol and Fisetin appear to be the highly promising drugs against MARK4-based targets, followed by Quercetin, Resveratrol, and Apigenin."], "CopyrightInformation": "Copyright \u00a9 2022 Ahmed, Mobashir, Al-Keridis, Alshammari, Adnan, Abid and Hassan."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences, Faculty of Natural Science, Jamia Millia Islamia, New Delhi, India."}, {"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Ahmed", "ForeName": "Sarfraz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences, Faculty of Natural Science, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Mobashir", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia."}], "LastName": "Al-Keridis", "ForeName": "Lamya Ahmed", "Initials": "LA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia."}], "LastName": "Alshammari", "ForeName": "Nawaf", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia."}], "LastName": "Adnan", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences, Faculty of Natural Science, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Abid", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, Yang S, et al. . A Map of Human Cancer Signaling. Mol Syst Biol (2007) 3:1\u201313. doi:\u00a010.1038/msb4100200", "ArticleIdList": ["10.1038/msb4100200", "PMC2174632", "18091723"]}, {"Citation": "Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell (2011) 144:646\u201374. doi:\u00a010.1016/j.cell.2011.02.013", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J. Cancer: A Systems Biology Disease. Biosystems (2006) 83:81\u201390. doi:\u00a010.1016/j.biosystems.2005.05.014", "ArticleIdList": ["10.1016/j.biosystems.2005.05.014", "16426740"]}, {"Citation": "Saraste A, Pulkki K. Morphologic and Biochemical Hallmarks of Apoptosis. Cardiovasc Res (2000) 45:528\u201337. doi: 10.1016/S0008-6363(99)00384-3", "ArticleIdList": ["10.1016/S0008-6363(99)00384-3", "10728374"]}, {"Citation": "Consortium, T. I. C. G. committee, E. committee, E. A. P. group, T. A. C. A. W. group, T. W. group, B. A. W et al. . PERSPECTIVES. Nature (2010) 464:993\u20138. doi:\u00a010.1038/nature08987", "ArticleIdList": ["10.1038/nature08987"]}, {"Citation": "El-Serag HB. Hepatocellular Carcinoma. New Engl J Med (2011) 365:1118\u201327. doi:\u00a010.1056/NEJMra1001683", "ArticleIdList": ["10.1056/NEJMra1001683", "21992124"]}, {"Citation": "Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, et al. . Identification of Overexpressed Genes in Hepatocellular Carcinoma, With Special Reference to Ubiquitin-Conjugating Enzyme E2Cgene Expression. Int J Cancer (2007) 121:33\u20138. doi:\u00a010.1016/S0002-9440(10)65248-0", "ArticleIdList": ["10.1016/S0002-9440(10)65248-0", "17354233"]}, {"Citation": "Llovet JM, Villanueva A, Lachenmayer A, Finn RS. Advances in Targeted Therapies for Hepatocellular Carcinoma in the Genomic Era. Nat Rev Clin Oncol (2015) 12:408\u201324. doi:\u00a010.1038/nrclinonc.2015.103", "ArticleIdList": ["10.1038/nrclinonc.2015.103", "26054909"]}, {"Citation": "Nalesnik MA, Tseng G, Ding Y, Xiang GS, Zheng Z, Yu YP, et al. . Gene Deletions and Amplifications in Human Hepatocellular Carcinomas. Am J Pathol (2012) 180:1495\u2013508. doi:\u00a010.1016/j.ajpath.2011.12.021", "ArticleIdList": ["10.1016/j.ajpath.2011.12.021", "PMC3657620", "22326833"]}, {"Citation": "Araya CL, Cenik C, Reuter JA, Kiss G, Pande VS, Snyder MP, et al. . Identification of Significantly Mutated Regions Across Cancer Types Highlights a Rich Landscape of Functional Molecular Alterations. Nat Genet (2015) 48:117\u201325. doi:\u00a010.1038/ng.3471", "ArticleIdList": ["10.1038/ng.3471", "PMC4731297", "26691984"]}, {"Citation": "Cheung KJ, Ewald AJ. A Collective Route to Metastasis: Seeding by Tumor Cell Clusters. Science (2016) 352:167\u20139. doi:\u00a010.1038/nature15748", "ArticleIdList": ["10.1038/nature15748", "PMC8183671", "27124449"]}, {"Citation": "Elkon R, Ugalde AP, Agami R. Alternative Cleavage Andpolyadenylation: Extent, Regulationand Function. Nat Rev Genet (2013) 14:496\u2013506. doi:\u00a010.1038/nrg3482", "ArticleIdList": ["10.1038/nrg3482", "23774734"]}, {"Citation": "Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK, et al. . DNA Methylome Analysis in Burkitt and Follicular Lymphomas Identifies Differentially Methylated Regions Linked to Somatic Mutation and Transcriptional Control. Nat Genet (2015) 47:1316\u201325. doi:\u00a010.1038/ng.3413", "ArticleIdList": ["10.1038/ng.3413", "PMC5444523", "26437030"]}, {"Citation": "Taylor BS, Barretina J, Maki RG, Antonescu CR, Singer S, Ladanyi M. Advances in Sarcoma Genomics and New Therapeutic Targets. Nat Publ Group (2011) 11:541\u201357. doi:\u00a010.1038/nrc3087", "ArticleIdList": ["10.1038/nrc3087", "PMC3361898", "21753790"]}, {"Citation": "Alexander S, Friedl P. Cancer Invasion and Resistance: Interconnected Processes of Disease Progression and Therapy Failure. Trends Mol Med (2012) 18:13\u201326. doi:\u00a010.1016/j.molmed.2011.11.003", "ArticleIdList": ["10.1016/j.molmed.2011.11.003", "22177734"]}, {"Citation": "Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, et al. . Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiationof Antigen-Presenting Cells. Immunity (2013) 38:729\u201341. doi:\u00a010.1016/j.immuni.2013.03.003", "ArticleIdList": ["10.1016/j.immuni.2013.03.003", "23562161"]}, {"Citation": "Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho H-I, Antonia S, et al. . Chemotherapy Enhances Tumor Cell Susceptibility to CTL-Mediated Killing During Cancer Immunotherapy in Mice. J Clin Invest (2010) 120:1111\u201324. doi:\u00a010.1172/JCI40269DS1", "ArticleIdList": ["10.1172/JCI40269DS1", "PMC2846048", "20234093"]}, {"Citation": "Kumar PP, Kamal MA, Warsi MK, Alnajeebi A, Ali HA, Helmi N, et al. . In-Silico Study Reveals Immunological Signaling Pathways, Their Genes, and Potential Herbal Drug Targets in Ovarian Cancer. Inf Med Unlocked (2020) 20:100422. doi: 10.1016/j.imu.2020.100422", "ArticleIdList": ["10.1016/j.imu.2020.100422"]}, {"Citation": "Purdie S, Creighton N, White KM, Baker D, Ewald D, Lee CK, et al. . Pathways to Diagnosis of non-Small Cell Lung Cancer: Adescriptive Cohort Study. NPJ Primary Care Respir Med (2019) 29:1\u20136. doi:\u00a010.1038/s41533-018-0113-7", "ArticleIdList": ["10.1038/s41533-018-0113-7", "PMC6368611", "30737397"]}, {"Citation": "Wang L, Wheeler DA. Genomic Sequencing for Cancer Diagnosis and Therapy. Annu Rev Med (2014) 65:33\u201348. doi:\u00a010.1146/annurev-med-120811-171056", "ArticleIdList": ["10.1146/annurev-med-120811-171056", "24274147"]}, {"Citation": "Gorski DH. Integrative Oncology:Really the Best of Both Worlds? Nat Rev Cancer (2014) 14:1\u20139. doi:\u00a010.1038/nrc3822", "ArticleIdList": ["10.1038/nrc3822", "25230880"]}, {"Citation": "Patel K, Gadewar M, Tahilyani V, Patel DK. A Review on Pharmacological and Analytical Aspects of Diosmetin: A Concise Report. Chin J Integr Med (2013) 19:792\u2013800. doi:\u00a010.1007/s11655-013-1595-3", "ArticleIdList": ["10.1007/s11655-013-1595-3", "24092244"]}, {"Citation": "Zhang J, Yang PL, Gray NS. Targeting Cancer With Small Molecule Kinase Inhibitors. Nat Rev Cancer (2009) 9:28\u201339. doi:\u00a010.1038/nrc2559", "ArticleIdList": ["10.1038/nrc2559", "19104514"]}, {"Citation": "Anjum F, Mohammad T, Almalki AA, Akhtar O, Abdullaev B, Hassan MI. Phytoconstituents and Medicinal plants for anticancer drug discovery: computational identification of potent inhibitors of PIM1 kinase OMICS: J Integrat Biol 25(9):580\u201390.", "ArticleIdList": ["34448628"]}, {"Citation": "Anwar S, Khan S, Anjum F, Shamsi A, Khan P, Fatima H, et al. . Myricetin Inhibits Breast and Lung Cancer Cells Proliferation via Inhibiting MARK4. J Cell Biochem (2022) 23(2):359\u201374. doi:\u00a010.1002/jcb.30176", "ArticleIdList": ["10.1002/jcb.30176", "34751461"]}, {"Citation": "Anwar S, Khan S, Shamsi A, Anjum F, Shafie A, Islam A, Ahmad F. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. J Cell Biochem 122(10):1445\u201359.", "ArticleIdList": ["34121218"]}, {"Citation": "Anwar S, Shamsi A, Shahbaaz M, Queen A, Khan P, Hasan GM, et al. . Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition. Sci Rep (2020) 10(1):10300. doi:\u00a010.1038/s41598-020-65648-z", "ArticleIdList": ["10.1038/s41598-020-65648-z", "PMC7316822", "32587267"]}, {"Citation": "Mohammad T, Khan FI, Lobb KA, Islam A, Ahmad F, Hassan MI. Identification and Evaluation of Bioactive Natural Products as Potential Inhibitors of Human Microtubule Affinity-Regulating Kinase 4 (MARK4). J Biomol Structure Dynamics (2018) 37:1\u201340. doi:\u00a010.1080/07391102.2018.1468282", "ArticleIdList": ["10.1080/07391102.2018.1468282", "29683402"]}, {"Citation": "Naz F, Anjum F, Islam A, Ahmad F, Hassan MI. Microtubule Affinity-Regulating Kinase 4: Structure, Function, and Regulation. Cell Biochem Biophys (2013) 67:485\u201399. doi:\u00a010.1007/s12013-013-9550-7", "ArticleIdList": ["10.1007/s12013-013-9550-7", "23471664"]}, {"Citation": "Naz F, Islam A, Ahmad F, Hassan MI. Atypical PKC Phosphorylates Microtubule Affinity-Regulating Kinase 4 In Vitro . Mol Cell Biochem (2015) 410:223\u20138. doi:\u00a010.1007/s11010-015-2555-3", "ArticleIdList": ["10.1007/s11010-015-2555-3", "26346160"]}, {"Citation": "Naz F, Sami N, Islam A, Ahmad F, Hassan Md I. Ubiquitin-Associated Domain of MARK4 Provides Stability at Physiological pH. Int J Biol Macromol (2016), 93:1\u201331. doi:\u00a010.1016/j.ijbiomac.2016.09.087", "ArticleIdList": ["10.1016/j.ijbiomac.2016.09.087", "27677563"]}, {"Citation": "Trinczek B, Brajenovic M, Ebneth A, Drewes G. MARK4 Is a Novel Microtubule-Associated Proteins/Microtubule Affinity-Regulating Kinase That Binds to the Cellular Microtubule Network and to Centrosomes*. J Biol Chem (2004) 279:5915\u201323. doi:\u00a010.1074/jbc.M304528200", "ArticleIdList": ["10.1074/jbc.M304528200", "14594945"]}, {"Citation": "Heidary Arash E, Shiban A, Song S, Attisano L. MARK4 Inhibits Hippo Signaling to Promote Proliferation and Migration of Breast Cancer Cells. EMBO Rep (2017) 18:420\u201336. doi:\u00a010.15252/embr.201642455", "ArticleIdList": ["10.15252/embr.201642455", "PMC5331264", "28183853"]}, {"Citation": "Jenardhanan P, Mannu J, Mathur PP. The Structural Analysis of MARK4 and the Exploration of Specific Inhibitors for the MARK Family: A Computational Approach to Obstruct the Role of MARK4 in Prostate Cancer Progression. Mol Biosyst (2014) 10:1845\u201368. doi:\u00a010.1039/c3mb70591a", "ArticleIdList": ["10.1039/c3mb70591a", "24763618"]}, {"Citation": "Li L, Guan K-L. Microtubule-Associated Protein/ Microtubule Affinity-Regulating Kinase 4 (MARK4) Is a Negative Regulator of the Mammalian Target of Rapamycin Complex 1. J Biol Chem (2013) 288:703\u20138. doi:\u00a010.1074/jbc.C112.396903", "ArticleIdList": ["10.1074/jbc.C112.396903", "PMC3537069", "23184942"]}, {"Citation": "Naz F, Sami N, Naqvi AT, Islam A, Ahmad F, Hassan MI, et al. . Evaluation of Human Microtubule Affinity- Regulating Kinase 4 Inhibitors: Fluorescence Binding Studies, Enzyme, and Cell Assays. J Biomol Structure Dynamics (2016), 35:1\u20130. doi:\u00a010.1080/07391102.2016.1249958", "ArticleIdList": ["10.1080/07391102.2016.1249958", "27748164"]}, {"Citation": "Magiera MM, Singh P, Gadadhar S, Janke C. Tubulin Posttranslational Modifications and Emerging Links to Human Disease. Cell (2018) 173:1323\u20137. doi:\u00a010.1016/j.cell.2018.05.018", "ArticleIdList": ["10.1016/j.cell.2018.05.018", "29856952"]}, {"Citation": "Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, et al. . MAP4K Family Kinases Act in Parallel to MST1/2 to Activate LATS1/2 in the Hippo Pathway. Nat Commun (2019), 6:1\u201313. doi:\u00a010.1038/ncomms9357", "ArticleIdList": ["10.1038/ncomms9357", "PMC4600732", "26437443"]}, {"Citation": "Naqvi AAT, Jairajpuri DS, Noman OMA, Hussain A, Islam A, Ahmad F. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer\u2019s disease. J Biomolecul Struct Dynam 38(13):3892\u2013907.", "ArticleIdList": ["31512980"]}, {"Citation": "Naz F, Khan FI, Mohammad T, Khan P, Manzoor S, Hasan GM, Lobb KA, et al. . Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. Intern J Biologic Macromolecul 107:2580\u201389.", "ArticleIdList": ["29079437"]}, {"Citation": "Parveen I, Khan P, Ali S, Hassan MI, Ahmed N. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors. J Medic Chem 159:166\u201377.", "ArticleIdList": ["30290280"]}, {"Citation": "Peerzada MN, Khan P, Khan NS, Gaur A, Avecilla F, Hassan MI, Azam A, et al. . Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis. N J Chem 44(38):16626\u201337."}, {"Citation": "Peerzada MN, Khan P, Khan NS, Avecilla F, Siddiqui SM, Hassan MI, et al. . Design and development of small-molecule arylaldoxime/5-nitroimidazole hybrids as potent inhibitors of MARK4: a promising approach for target-based cancer therapy. ACS Omega 5(36):22759\u201371.", "ArticleIdList": ["PMC7495461", "32954123"]}, {"Citation": "Anwar S, Shamsi A, Shahbaaz M, Queen A, Khan P, Hasan GM, Islam A, et al. . Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Scientific Reports 10(1):1\u201313.", "ArticleIdList": ["PMC7316822", "32587267"]}, {"Citation": "Waseem R, Anwar S, Khan S, Shamsi A, Hassan MI, Anjum F, Shafie A, et al. . MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer\u2019s Disease. Intern J Molecul Sci 22(20):10986.", "ArticleIdList": ["PMC8537121", "34681645"]}, {"Citation": "Brooijmans N, Kuntz ID. Molecular Recognition and Docking Algorithms. Annu Rev Biophys Biomol Struct (2003) 32:335\u201373. doi:\u00a010.1146/annurev.biophys.32.110601.142532", "ArticleIdList": ["10.1146/annurev.biophys.32.110601.142532", "12574069"]}, {"Citation": "Galindez G, Matschinske J, Rose TD, Sadegh S, Salgado-Albarr\u00e1n M, Sp\u00e4th J, et al. . Lessons From the COVID-19 Pandemic for Advancing Computational Drug Repurposing Strategies. Nat Comput Sci (2021) 1:1\u20139. doi:\u00a010.1038/s43588-020-00007-6", "ArticleIdList": ["10.1038/s43588-020-00007-6"]}, {"Citation": "Grosdidier A, Zoete V, Michielin O. SwissDock, a Protein-Small Molecule Docking Web Service Based on EADock DSS. Nucleic Acids Res (2011) 39:W270\u20137. doi:\u00a010.1167/iovs.08-2145", "ArticleIdList": ["10.1167/iovs.08-2145", "PMC3125772", "21624888"]}, {"Citation": "Jensen ON. Interpreting the Protein Language Using Proteomics. Nat Rev Mol Cell Biol (2006) 7:391\u2013403. doi:\u00a010.1038/nrm1939", "ArticleIdList": ["10.1038/nrm1939", "16723975"]}, {"Citation": "Helmi N, Alammari D, Mobashir M. Role of Potential COVID-19 Immune System Associated Genes and the Potential Pathwayslinkage With Type-2 Diabetes. Combinatorial Chem High Throughput Screening (2021) 24:1\u201311. doi: 10.2174/1386207324666210804124416", "ArticleIdList": ["10.2174/1386207324666210804124416", "34348612"]}, {"Citation": "Kamal MA, Warsi MK, Alnajeebi A, Ali HA, Helmi N, Izhari MA, et al. . Gene Expression Profiling and Clinical Relevance Unravel the Role Hypoxia and Immune Signaling Genes and Pathways in Breast Cancer: Role of Hypoxia and Immune Signaling Genes in Breast Cancer. jimsa (2020) 1:2\u201310. doi: 10.36013/jimsa.v1i1.3", "ArticleIdList": ["10.36013/jimsa.v1i1.3"]}, {"Citation": "Ghosh S, Matsuoka Y, Asai Y, Hsin K-Y, Kitano H. Software for Systems Biology: From Tools to Integrated Platforms. Nat Rev Genet (2011) 12:821\u201332. doi:\u00a010.1038/nrg3096", "ArticleIdList": ["10.1038/nrg3096", "22048662"]}, {"Citation": "Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P. Computational Drug Repositioning: From Data to Therapeutics. Clin Pharmacol Ther (2013) 93:335\u201341. doi:\u00a010.1038/clpt.2013.1", "ArticleIdList": ["10.1038/clpt.2013.1", "23443757"]}, {"Citation": "Roider HG, Pavlova N, Kirov I, Slavov S, Slavov T, Uzunov Z, et al. . Drug2Gene: An Exhaustive Resource to Explore Effectively the Drug-Target Relation Network. BMC Bioinf (2014) 15:68. doi:\u00a010.1007/s11684-013-0277-z", "ArticleIdList": ["10.1007/s11684-013-0277-z", "PMC4234465", "24618344"]}, {"Citation": "Swainston N, Fleming RMT, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, et al. . A Community-Driven Global Reconstruction of Human Metabolism. Nat Biotechnol (2013) 31:1\u20139. doi:\u00a010.1038/nbt.2488", "ArticleIdList": ["10.1038/nbt.2488", "PMC3856361", "23455439"]}, {"Citation": "Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. . An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell (2018) 173:400\u2013416.e11. doi:\u00a010.1016/j.cell.2018.02.052", "ArticleIdList": ["10.1016/j.cell.2018.02.052", "PMC6066282", "29625055"]}, {"Citation": "Nelson PS. Beyond the Androgen Receptor: Targeting Actionable Drivers of Prostate Cancer. JCO Precis Oncol (2017) 1:1\u20133. doi:\u00a010.1200/PO.17.00064", "ArticleIdList": ["10.1200/PO.17.00064", "35172491"]}, {"Citation": "Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, et al. . Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell (2018) 33:676\u2013689.e3. doi:\u00a010.1016/j.ccell.2018.03.007", "ArticleIdList": ["10.1016/j.ccell.2018.03.007", "PMC6028190", "29622463"]}, {"Citation": "Werner HMJ, Mills GB, Ram PT. Cancer Systems Biology: A Peek Into the Future of Patient Care? Nat Rev Clin Oncol (2014) 11:167\u201376. doi: 10.1038/nrclinonc.2014.6", "ArticleIdList": ["10.1038/nrclinonc.2014.6", "PMC4321721", "24492837"]}, {"Citation": "Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res (2003) 13:2498\u2013504. doi:\u00a010.1101/gr.1239303", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Bajrai L, Sohrab SS, Alandijany TA, Mobashir M, Parveen S, Kamal MA, et al. . Gene Expression Profiling of Early Acute Febrile Stage of Dengue Infection and its Comparative Analysis With Streptococcus Pneumoniae Infection. Front Cell Infect Microbiol (2021), 11:1\u201330. doi:\u00a010.3389/fcimb.2021.707905", "ArticleIdList": ["10.3389/fcimb.2021.707905", "PMC8581568", "34778101"]}, {"Citation": "Bhat SA, Ahmad SM, Ibeagha-Awemu EM, Mobashir M, Dar MA, Mumtaz PT, et al. . Comparative Milk Proteome Analysis of Kashmiri and Jersey Cattle Identifies Differential Expression of Key Proteins Involved in Immune System Regulation and Milk Quality. BMC genomics (2020) 21:1\u201310. doi:\u00a010.1186/s12864-020-6574-4", "ArticleIdList": ["10.1186/s12864-020-6574-4", "PMC7023774", "32059637"]}, {"Citation": "\nMobashir M. Mathematical Modeling and Evolution of Signal Transduction Pathways and Networks. (2013). https://opendata.uni-halle.de/bitstream/1981185920/11745/1/ThesisAfterDefense.pdf\n"}, {"Citation": "Mobashir M, Schraven B, Beyer T. Simulated Evolution of Signal Transduction Networks. PloS One (2012) 7:e50905. doi: 10.1371/journal.pone.0050905", "ArticleIdList": ["10.1371/journal.pone.0050905", "PMC3521023", "23272078"]}, {"Citation": "Mobashir M, Madhusudhan T, Isermann B, Beyer T, Schraven B. Negative Interactions and Feedback Regulations Are Required for Transient Cellular Response. Sci Rep (2014) 4:1\u20138. doi:\u00a010.1038/srep03718", "ArticleIdList": ["10.1038/srep03718", "PMC3893651", "24430195"]}, {"Citation": "Mustafa S, Mobashir M. LC\u2013MS and Docking Profiling Reveals Potential Difference Between the Pure and Crude Fucoidan Metabolites. Int J Biol Macromol (2020) 143:11\u201329. doi:\u00a010.1016/j.ijbiomac.2019.11.232", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.232", "31811847"]}, {"Citation": "Alexeyenko A, Sonnhammer ELL. Global Networks of Functional Coupling in Eukaryotes From Comprehensive Data Integration. Genome Res (2009) 19:1107\u201316. doi:\u00a010.1101/gr.087528.108", "ArticleIdList": ["10.1101/gr.087528.108", "PMC2694487", "19246318"]}, {"Citation": "Bajrai LH, Sohrab SS, Mobashir M, Kamal MA, Rizvi MA, Azhar EI. Understanding the Role of Potential Pathways and its Components Including Hypoxia and Immune System in Case of Oral Cancer. Sci Rep (2021) 11:1\u201310. doi:\u00a010.1038/s41598-021-98031-7", "ArticleIdList": ["10.1038/s41598-021-98031-7", "PMC8486818", "34599215"]}, {"Citation": "Eldakhakhny BM, Al Sadoun H, Choudhry H, Mobashir M. In-Silico Study of Immune System Associated Genes in Case of Type-2 Diabetes With Insulin Action and Resistance, and/or Obesity. Front Endocrinol (2021) 12:641888/full. doi:\u00a010.3389/fendo.2021.641888/full", "ArticleIdList": ["10.3389/fendo.2021.641888/full", "PMC8078136", "33927693"]}, {"Citation": "Warsi MK, Kamal MA, Baeshen MN, Izhari MA, Mobashir M. Comparative Study of Gene Expression Profiling Unravels Functions Associated With Pathogenesis of Dengue Infection. Curr Pharm Design (2020) 26:1\u20138. doi: 10.2174/1381612826666201106093148", "ArticleIdList": ["10.2174/1381612826666201106093148", "33155901"]}, {"Citation": "Secrier M, Wiecek A, Cutty S, Kornai D, Parreno-Centeno M, Gourmet L, et al. . Genomic Hallmarks of Cellular Dormancy in Cancer and Therapeutic Implications."}, {"Citation": "West J, Bianconi G, Severini S, Teschendorff AE. Differential Network Entropy Reveals Cancer System Hallmarks. Sci Rep (2012) 2:1\u20138. doi:\u00a010.1038/srep00802", "ArticleIdList": ["10.1038/srep00802", "PMC3496163", "23150773"]}, {"Citation": "Naz A, Bano K, Bano F, Ghafoor N, Akhtar N. Conformational Analysis (Geometry Optimization) of Nucleosidic Antitumor Antibiotic Showdomycin by ArgusLab 4 Software. Pakistan J Pharm Sci (2009) 22:78\u201382.", "ArticleIdList": ["19168426"]}, {"Citation": "Naz F, Asad M, Malhotra P, Islam A, Ahmad F, Hassan MI. Cloning, Expression, Purification and Refolding of Microtubule Affinity-Regulating Kinase 4 Expressed in Escherichia Coli. Appl Biochem Biotechnol (2014) 172:2838\u201348. doi:\u00a010.1007/s12010-014-0733-5", "ArticleIdList": ["10.1007/s12010-014-0733-5", "24446173"]}, {"Citation": "Szyf M. PERSPECTIVES. Nat Publ Group (2015) 14:461\u201374. doi:\u00a010.1038/nrd4580", "ArticleIdList": ["10.1038/nrd4580"]}, {"Citation": "Aneja B, Khan NS, Khan P, Queen A, Hussain A, Rehman MT, et al. . Design and Development of Isatin-Triazole Hydrazones as Potential Inhibitors of Microtubule Affinity-Regulating Kinase 4 for the Therapeutic Management of Cell Proliferation and Metastasis. Eur J Med Chem (2019) 163:840\u201352. doi: 10.1016/j.ejmech.2018.12.026", "ArticleIdList": ["10.1016/j.ejmech.2018.12.026", "30579124"]}, {"Citation": "Khan P, Queen A, Mohammad T, Smita, Khan NS, Hafeez ZB, et al. . Identification of \u03b1-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4. J Nat Prod (2019) 82(8):2252\u201361. doi: 10.1021/acs.jnatprod.9b00372", "ArticleIdList": ["10.1021/acs.jnatprod.9b00372", "31343173"]}, {"Citation": "Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan GM, et al. . Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones. Sci Rep (2019) 9(1):1676. doi: 10.1038/s41598-018-38217-8", "ArticleIdList": ["10.1038/s41598-018-38217-8", "PMC6368574", "30737440"]}, {"Citation": "Johnson R, Halder G. The Two Faces of Hippo: Targetingthe Hippo Pathway for Regenerativemedicine and Cancer Treatment. Nat Publ Group (2013) 13:63\u201379. doi:\u00a010.1038/nrd4161", "ArticleIdList": ["10.1038/nrd4161", "PMC4167640", "24336504"]}, {"Citation": "Breinig M, Klein FA, Huber W, Boutros M. A Chemical-Genetic Interaction Map of Small Molecules Using High-Throughput Imaging in Cancer Cells. Mol Syst Biol (2015) 11:846\u20136. doi:\u00a010.15252/msb.20156400", "ArticleIdList": ["10.15252/msb.20156400", "PMC4704494", "26700849"]}, {"Citation": "Dienstmann R, Rodon J, Prat A, Perez-Garcia J, Adamo B, Felip E, et al. . Genomic Aberrations in the FGFR Pathway: Opportunities for Targeted Therapies in Solid Tumors. Ann Oncol (2014) 25:552\u201363. doi:\u00a010.1093/annonc/mdt419", "ArticleIdList": ["10.1093/annonc/mdt419", "PMC4433501", "24265351"]}, {"Citation": "Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ. Blockade of Epidermal Growth Factor Receptor Signaling Leads to Inhibition of Renal Cell Carcinoma Growth in the Bone of Nude Mice. Cancer Res (2003) 63:2940\u20137.", "ArticleIdList": ["12782601"]}, {"Citation": "Gerstberger S, Hafner M, Tuschl T. A Census of Human RNA-Binding Proteins. Nat Rev Genet (2014) 1\u201317:829\u201345. doi:\u00a010.1038/nrg3813", "ArticleIdList": ["10.1038/nrg3813", "25365966"]}, {"Citation": "Okawa S, Angarica VE, Lemischka I, Moore K, del Sol A. A Differential Network Analysis Approach for Lineagespeci. Nat Publ Group (2015) 1:1\u20138. doi:\u00a010.1038/npjsba.2015.12", "ArticleIdList": ["10.1038/npjsba.2015.12", "PMC5516870", "28725462"]}, {"Citation": "Krishnamoorthy PKP, Subasree S, Arthi U, Mobashir M, Gowda C, Revanasiddappa PD. T-Cell Epitope-Based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach. Combinatorial Chem High Throughput Screening (2020) 23:788\u201396. doi:\u00a010.2174/1386207323666200427114343", "ArticleIdList": ["10.2174/1386207323666200427114343", "32338213"]}, {"Citation": "Cragg GM, Newman DJ, Snader KM. Natural Products in Drug Discovery and Development. J Nat Prod (1997) 60:52\u201360. doi:\u00a010.1021/np9604893", "ArticleIdList": ["10.1021/np9604893", "9014353"]}, {"Citation": "Gholipour S, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects. Curr Pharm Design (2018) 24:3123\u201331. doi:\u00a010.2174/1381612824666180911121525", "ArticleIdList": ["10.2174/1381612824666180911121525", "30205790"]}, {"Citation": "Kirichenko TV, Sukhorukov VN, Markin AM, Nikiforov NG, Liu P-Y, Sobenin IA, et al. . Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis. Frontiers in Pharmacology (2020), 11:1\u201315. doi:\u00a010.3389/fphar.2020.00403/full", "ArticleIdList": ["10.3389/fphar.2020.00403/full", "PMC7156611", "32322201"]}, {"Citation": "Lee K-H. Current Developments in the Discovery and Design of New Drug Candidates From Plant Natural Product Leads. J Nat Prod (2004) 67:273\u201383. doi:\u00a010.1021/np030373o", "ArticleIdList": ["10.1021/np030373o", "14987069"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "6"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "8", "Day": "8", "Hour": "3", "Minute": "51"}, {"Year": "2022", "Month": "8", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35936719", "PMC9355243", "10.3389/fonc.2022.914032"]}}], "PubmedBookArticle": []}